Abnormal prefrontal activation directly related to pre-synaptic striatal dopamine dysfunction in people at clinical high risk for psychosis

Laruelle M . Schizophrenia is associated with increased synaptic dopamine in associative rather than limbic regions of the striatum: implications for the mechanisms of actions of antipsychotic drugs. Schizophr Res 2006; 81: 16.

Howes OD, Montgomery AJ, Asselin M, Murray R, Grasby P, McGuire P . Molecular imaging studies of the striatal dopaminergic system in psychosis and predictions for the prodromal phase of psychosis. Br J Psychiatry 2007; S51: s13–s18.

Weinberger DR, Berman KF . Prefrontal function in schizophrenia: confounds and controversies. Philos Trans R Soc Lond B Biol Sci 1996; 351: 1495–1503.

Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 2001; 50: 825–844.

Curtis VA, Bullmore ET, Brammer MJ, Wright IC, Williams SC, Morris RG et al. Attenuated frontal activation during a verbal fluency task in patients with schizophrenia. Am J Psychiatry 1998; 155: 1056–1063.

Fu CH, Morgan K, Suckling J, Williams SC, Andrew C, Vythelingum GN et al. A functional magnetic resonance imaging study of overt letter verbal fluency using a clustered acquisition sequence: greater anterior cingulate activation with increased task demand. Neuroimage 2002; 17: 871–879.

Reichenberg A, Harvey PD . Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychol Bull 2007; 133: 833–858.

Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell'Olio M et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States. Aust N Z J Psychiatry 2005; 39: 964–971.

Cannon TD, Cornblatt B, McGorry P . The empirical status of the ultra high-risk (prodromal) research paradigm. Schizophr Bull 2007; 33: 661–664.

Phillips LJ, McGorry PD, Yung AR, McGlashan TH, Cornblatt B, Klosterkotter J . Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities. Br J Psychiatry Suppl 2005; 48: s33–s44.

Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry 2006; 59: 863–871.

Pukrop R, Schultze-Lutter F, Ruhrmann S, Brockhaus-Dumke A, Tendolkar I, Bechdolf A et al. Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. J Clin Exp Neuropsychol 2006; 28: 1388–1407.

Simon AE, Cattapan-Ludewig K, Zmilacher S, Arbach D, Gruber K, Dvorsky DN et al. Cognitive functioning in the schizophrenia prodrome. Schizophr Bull 2007; 33: 761–771.

Fusar-Poli P, Perez J, Broome MR, Borgwardt S, Placentino A, Caverzasi E et al. Neurofunctional correlates of liability to psychosis: a systematic review and meta-analysis. Neur Biob Rev 2007; 31: 465–484.

Howes O, Montgomery A, Asselin M, Valli I, Tabraham P, Johns L et al. Elevated striatal dopamine function linked to prodromal signs of schizophrenia. Archives of General Psychiatry 2009; 66: 13–20.

Tepper JM, Bolam JP . Functional diversity and specificity of neostriatal interneurons. Curr Opin Neurobiol 2004; 14: 685–692.

Holt DJ, Graybiel AM, Saper CB . Neurochemical architecture of the human striatum. J Comp Neurol 1997; 384: 1–25.

Voorn P, Vanderschuren LJ, Groenewegen HJ, Robbins TW, Pennartz CM . Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 2004; 27: 468–474.

Meyer-Lindenberg A, Miletich RS, Kohn PD, Esposito G, Carson RE, Quarantelli M et al. Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci 2002; 5: 267–271.

Alves Fda S, Figee M, Vamelsvoort T, Veltman D, Haan L . The revised dopamine hypothesis of schizophrenia: evidence from pharmacological MRI studies with atypical antipsychotic medication. Psychopharmacol Bull 2008; 41: 121–132.

Vita A, De Peri L . The effects of antipsychotic treatment on cerebral structure and function in schizophrenia. Int Rev Psychiatry 2007; 19: 429–436.

Morey RA, Inan S, Mitchell TV, Perkins DO, Lieberman JA, Belger A . Imaging frontostriatal function in ultra-high-risk, early, and chronic schizophrenia during executive processing. Arch Gen Psychiatry 2005; 62: 254–262.

Broome M, Woolley J, Tabraham P, Johns L, Bramon E, Murray G et al. What causes the onset of psychosis? Schizophr Res 2005; 79: 23–34.

Coren S . Measurement of handedness via self-report: the relationship between brief and extended inventories. Percept Mot Skills 1993; 76 (3 Pt 1): 1035–1042.

Kay SR . Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison. Psychiatr Q 1990; 61: 163–178.

Barkus EJ, Stirling J, Hopkins RS, Lewis S . Cannabis-induced psychosis-like experiences are associated with high schizotypy. Psychopathology 2006; 39: 175–178.

Nelson HE, Willison JR . National Adult Reading Test (NART): Test Manual 2nd ed. NFER-Nelson Windsor: England, 1991.

Costafreda SG, Fu CH, Lee L, Everitt B, Brammer MJ, David AS . A systematic review and quantitative appraisal of fMRI studies of verbal fluency: role of the left inferior frontal gyrus. Hum Brain Mapp 2006; 27: 799–810.

Maldjian J, Laurienti P, Kraft R, Burdette J . An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. NeuroImage 2003; 19: 1233–1239.

Spinks TJ, Jones T, Bloomfield PM, Bailey DL, Miller M, Hogg D et al. Physical characteristics of the ECAT EXACT3D positron tomograph. Phys Med Biol 2000; 45: 2601–2618.

Ishikawa T, Dhawan V, Chaly T, Robeson W, Belakhlef A, Mandel F et al. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis. J Cereb Blood Flow Metab 1996; 16: 854–863.

Sawle GV, Burn DJ, Morrish PK, Lammertsma AA, Snow BJ, Luthra S et al. The effect of entacapone (OR-611) on brain -6-L-fluorodopa metabolism: implications for levodopa therapy of Parkinson's disease. Neurology 1994; 44: 1292–1297.

Wahl L, Chirakal R, Firnau G, Garnett ES, Nahmias C . The distribution and kinetics of [18F]6-fluoro-3-O-methyl-L-dopa in the human brain. J Cereb Blood Flow Metab 1994; 14: 664–670.

Turkheimer FE, Brett M, Visvikis D, Cunningham VJ . Multiresolution analysis of emission tomography images in the wavelet domain. J Cereb Blood Flow Metab 1999)); 19: 1189–1208.

Studholme C, Hill DL, Hawkes DJ . Automated 3-D registration of MR and CT images of the head. Med Image Anal 1996; 1: 163–175.

Montgomery AJ, Thielemans K, Mehta MA, Turkheimer F, Mustafovic S, Grasby PM . Correction of head movement on PET studies: comparison of methods. J Nucl Med 2006; 47: 1936–1944.

Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L et al. Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 2003; 19: 224–247.

Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001; 21: 1034–1057.

McGowan S, Lawrence AD, Sales T, Quested D, Grasby P . Presynaptic dopaminergic dysfunction in schizophrenia: a positron emission tomographic fluorodopa study. Arch Gen Psychiatry 2004; 61: 134–142.

Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y et al. Imaging human mesolimbic dopamine transmission with positron emission tomography.Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003; 23: 285–300.

Patlak CS, Blasberg RG, Fenstermacher JD . Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1–7.

Moore RY, Whone AL, McGowan S, Brooks DJ . Monoamine neuron innervation of the normal human brain: an 18F-DOPA PET study. Brain Res 2003; 982: 137–145.

Fu CH, Suckling J, Williams SC, Andrew CM, Vythelingum GN, McGuire PK . Effects of psychotic state and task demand on prefrontal function in schizophrenia: an fMRI study of overt verbal fluency. Am J Psychiatry 2005; 162: 485–494.

Price CJ, Friston KJ . Scanning patients with tasks they can perform. Hum Brain Mapp 1999; 8: 102–108.

Tan HY, Callicott JH, Weinberger DR . Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb Cortex 2007; 17 Suppl 1: i171–i181.

Fusar-Poli P, Broome M, Matthiasson P, Woolley J, Mechelli A, Johns L et al. Prefrontal response during executive functioning at presentation directly related to twelve months clinical outcome in people at ultra high risk of psychosis. Schizophrenia Bulletin; 7 August 2009 [e-pub ahead of print].

Borgwardt SJ, Riecher-Rossler A, Dazzan P, Chitnis X, Aston J, Drewe M et al. Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 2007; 61: 1148–1156.

Meisenzahl EM, Koutsouleris N, Gaser C, Bottlender R, Schmitt GJ, McGuire P et al. Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study. Schizophr Res 2008; 102: 150–162.

Garcia-Marti G, Aguilar EJ, Lull JJ, Marti-Bonmati L, Escarti MJ, Manjon JV et al. Schizophrenia with auditory hallucinations: a voxel-based morphometry study. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32: 72–80.

Antonova E, Kumari V, Morris R, Halari R, Anilkumar A, Mehrotra R et al. The relationship of structural alterations to cognitive deficits in schizophrenia: a voxel-based morphometry study. Biol Psychiatry 2005; 58: 457–467.

Borgwardt SJ, McGuire PK, Aston J, Berger G, Dazzan P, Gschwandtner U et al. Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br J Psychiatry Suppl 2007; 51: s69–s75.

Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 2003; 361: 281–288.

Sun D, Phillips L, Velakoulis D, Yung A, McGorry P, Wood S et al. Progressive brain structural changes mapped as psychosis develops in ‘at risk’ individuals. Schizophr Res 2009; 108: 85–92.

Laruelle M, Abi-Dargham A . Dopamine as the wind of the psychotic fire: new evidence from brain imaging studies. J Psychopharmacol 1999; 13: 358–371.

Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R . Increased dopamine transmission in schizophrenia: relationship to illness phases. Biol Psychiatry 1999; 46: 56–72.

Alexander GE, DeLong MR, Strick PL . Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 1986; 9: 357–381.

Fusar-Poli P, Allen P, McGuire P . Neuroimaging studies of the early stages of psychosis: a critical review. Eur Psychiatry 2008; 23: 237–244.

Prata D, Mechelli A, Fu C, Picchioni M, Kane F, Kalidindi S et al. Opposite effects of COMT Val158Met on cortical function inof healthy subjects and patients with schizophrenia. Biol Psychiatry 2008 (in press).

Nakano K, Kayahara T, Tsutsumi T, Ushiro H . Neural circuits and functional organization of the striatum. J Neurol 2000; 247 Suppl 5: 6–15.

Guillin O, Abi-Dargham A, Laruelle M . Neurobiology of dopamine in schizophrenia. Int Rev Neurobiol 2007; 78: 1–39.

Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML . Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 2001; 41: 237–260.

Kellendonk C, Simpson EH, Polan HJ, Malleret G, Vronskaya S, Winiger V et al. Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning. Neuron 2006; 49: 603–615.

Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 2008; 65: 28–37.

Howes O, Kapur S . The Dopamine Hypothesis of Schizophrenia: Version III -The Final Common Pathway. Schizophr Bull 2009; 35: 549–562.

Meisenzahl EM, Schmitt GJ, Scheuerecker J, Moller HJ . The role of dopamine for the pathophysiology of schizophrenia. Int Rev Psychiatry 2007; 19: 337–345.